Aqr Capital Management LLC Intra Cellular Therapies, Inc. Transaction History

Aqr Capital Management LLC

  • $71.5 Billion
  • Q3 2024

A detailed history of Aqr Capital Management LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 461,832 shares of ITCI stock, worth $38.4 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
461,832
Previous 105,431 338.04%
Holding current value
$38.4 Million
Previous $7.22 Million 367.71%
% of portfolio
0.05%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$67.99 - $80.84 $24.2 Million - $28.8 Million
356,401 Added 338.04%
461,832 $33.8 Million
Q2 2024

Aug 14, 2024
BUY
$64.76 - $79.84 $1.72 Million - $2.11 Million
26,486 Added 33.55%
105,431 $7.22 Million
Q1 2024

May 15, 2024
BUY
$64.37 - $75.65 $2.59 Million - $3.04 Million
40,232 Added 103.92%
78,945 $5.46 Million
Q4 2023

Feb 14, 2024
BUY
$46.37 - $73.65 $406,850 - $646,205
8,774 Added 29.31%
38,713 $2.77 Million
Q3 2023

Nov 14, 2023
BUY
$52.09 - $64.1 $718,477 - $884,131
13,793 Added 85.43%
29,939 $1.56 Million
Q2 2023

Aug 14, 2023
BUY
$54.67 - $66.44 $147,444 - $179,188
2,697 Added 20.05%
16,146 $1.02 Million
Q1 2023

May 15, 2023
SELL
$43.8 - $56.99 $242,739 - $315,838
-5,542 Reduced 29.18%
13,449 $728,000
Q4 2022

Feb 14, 2023
SELL
$44.07 - $54.45 $59,670 - $73,725
-1,354 Reduced 6.66%
18,991 $1.01 Million
Q3 2022

Nov 14, 2022
SELL
$42.7 - $59.99 $115,375 - $162,092
-2,702 Reduced 11.72%
20,345 $947,000
Q2 2022

Aug 15, 2022
BUY
$43.0 - $65.64 $568,546 - $867,892
13,222 Added 134.58%
23,047 $1.32 Million
Q1 2022

May 16, 2022
BUY
$38.74 - $62.09 $50,478 - $80,903
1,303 Added 15.29%
9,825 $601,000
Q2 2021

Aug 16, 2021
SELL
$29.3 - $44.5 $289,249 - $439,304
-9,872 Reduced 53.67%
8,522 $348,000
Q1 2021

May 17, 2021
SELL
$30.8 - $39.51 $444,782 - $570,563
-14,441 Reduced 43.98%
18,394 $624,000
Q4 2020

Feb 16, 2021
SELL
$23.34 - $32.22 $439,095 - $606,154
-18,813 Reduced 36.43%
32,835 $1.04 Million
Q3 2020

Nov 16, 2020
SELL
$17.61 - $31.86 $181,066 - $327,584
-10,282 Reduced 16.6%
51,648 $1.33 Million
Q2 2020

Aug 17, 2020
BUY
$14.35 - $26.64 $8,839 - $16,410
616 Added 1.0%
61,930 $1.59 Million
Q1 2020

May 15, 2020
BUY
$12.31 - $33.12 $754,775 - $2.03 Million
61,314 New
61,314 $942,000
Q1 2019

May 14, 2019
SELL
$10.9 - $14.09 $216,223 - $279,503
-19,837 Closed
0 $0
Q4 2018

Feb 14, 2019
SELL
$10.36 - $20.96 $54,649 - $110,564
-5,275 Reduced 21.01%
19,837 $226,000
Q3 2018

Nov 15, 2018
BUY
$17.77 - $22.9 $2,594 - $3,343
146 Added 0.58%
25,112 $545,000
Q2 2018

Aug 14, 2018
BUY
$17.33 - $23.4 $432,660 - $584,204
24,966 New
24,966 $441,000

Others Institutions Holding ITCI

# of Institutions
378
Shares Held
84.7M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $7.85B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email